Bis(3,5-ditert-butyl-1,2,4-oxadiazole);2,4-ditert-butyl-1,3-oxazole;bis(3,5-ditert-butyl-1,2-oxazole)
C53H93N7O5 — CID 159027746
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis(3,5-ditert-butyl-1,2,4-oxadiazole);2,4-ditert-butyl-1,3-oxazole;bis(3,5-ditert-butyl-1,2-oxazole)
Bis(3,5-ditert-butyl-1,2,4-oxadiazole);2,4-ditert-butyl-1,3-oxazole;bis(3,5-ditert-butyl-1,2-oxazole) (PubChem CID 159027746) has the molecular formula C53H93N7O5 and a molecular weight of 908.37 g/mol. Its IUPAC name is bis(3,5-ditert-butyl-1,2,4-oxadiazole);2,4-ditert-butyl-1,3-oxazole;bis(3,5-ditert-butyl-1,2-oxazole).
Molecular Properties
| Compound Name | Bis(3,5-ditert-butyl-1,2,4-oxadiazole);2,4-ditert-butyl-1,3-oxazole;bis(3,5-ditert-butyl-1,2-oxazole) |
|---|---|
| PubChem CID | 159027746 |
| Molecular Formula | C53H93N7O5 |
| Molecular Weight | 908.37 g/mol |
| Exact Mass | 907.72 |
| IUPAC Name | bis(3,5-ditert-butyl-1,2,4-oxadiazole);2,4-ditert-butyl-1,3-oxazole;bis(3,5-ditert-butyl-1,2-oxazole) |
| SMILES | CC(C)(C)c1cc(C(C)(C)C)on1.CC(C)(C)c1cc(C(C)(C)C)on1.CC(C)(C)c1coc(C(C)(C)C)n1.CC(C)(C)c1noc(C(C)(C)C)n1.CC(C)(C)c1noc(C(C)(C)C)n1 |
| InChI | InChI=1S/3C11H19NO.2C10H18N2O/c1-10(2,3)8-7-13-9(12-8)11(4,5)6;2*1-10(2,3)8-7-9(13-12-8)11(4,5)6;2*1-9(2,3)7-11-8(13-12-7)10(4,5)6/h3*7H,1-6H3;2*1-6H3 |
| InChIKey | JUMINHBUEVBOQV-UHFFFAOYSA-N |
| XLogP | 15.14 |
| TPSA | 155.93 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | |
| Heavy Atoms | 65 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 908.37 |
| LogP ≤ 5 | 15.14 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159027746 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.